Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Post by Sosak1on Dec 04, 2021 3:38pm
389 Views
Post# 34198809

Our competition Keytruda side effects & only 19% CR

Our competition Keytruda side effects & only 19% CR

Keytruda Side Effects

Generic name: pembrolizumab

Medically reviewed by Drugs.com. Last updated on Jul 4, 2021.

Note: This document contains side effect information about pembrolizumab. Some of the dosage forms listed on this page may not apply to the brand name Keytruda.

For the Consumer

Applies to pembrolizumab: intravenous solution

Side effects requiring immediate medical attention

Along with its needed effects, pembrolizumab (the active ingredient contained in Keytruda) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking pembrolizumab:

More common

  • Black, tarry stools
  • bladder pain
  • bloating or swelling of the face, arms, hands, lower legs, or feet
  • bloody or cloudy urine
  • blurred vision
  • body aches or pain
  • burning, numbness, tingling, or painful sensations
  • chills
  • clay-colored stools
  • confusion
  • constipation
  • cough
  • dark urine
  • decreased appetite
  • depressed mood
  • difficult, burning, or painful urination
  • difficulty with breathing
  • difficulty with moving
  • dizziness
  • dry mouth
  • dry skin and hair
  • ear congestion
  • feeling cold
  • fever
  • flushing
  • frequent urge to urinate
  • fruit-like breath odor
  • hair loss
  • headache
  • hoarseness or husky voice
  • increased hunger
  • increased thirst
  • increased urination
  • itching, skin rash
  • joint or bone pain
  • loss of voice
  • lower back or side pain
  • mood or mental changes
  • muscle cramps, pain, and stiffness
  • nausea
  • neck pain
  • nervousness
  • numbness and tingling around the mouth, fingertips, or feet
  • painful or difficult urination
  • pale skin
  • pounding in the ears
  • rapid weight gain
  • redness, swelling, or pain of the skin
  • runny or stuffy nose
  • scaling of the skin on the hands and feet
  • slow or fast heartbeat
  • sneezing
  • sore throat
  • sores, ulcers, or white spots on the lips or in the mouth
  • stomach cramps, pain or tenderness
  • swelling of the face, ankles, or hands
  • tingling of the hands or feet
  • ulceration of the skin
  • unsteadiness or awkwardness
  • unusual bleeding or bruising
  • unusual tiredness or weakness
  • unusual weight gain or loss
  • vomiting
  • weakness in the arms, hands, legs, or feet
  • yellow eyes or skin

<< Previous
Bullboard Posts
Next >>